Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Oncology Institute Inc (NASDAQ: TOI) was $3.53 for the day, down -8.31% from the previous closing price of $3.85. In other words, the price has decreased by -$8.31 from its previous closing price. On the day, 2.2 million shares were traded. TOI stock price reached its highest trading level at $3.88 during the session, while it also had its lowest trading level at $3.52.
Ratios:
Our analysis of TOI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.68.
Upgrades & Downgrades
In the most recent recommendation for this company, Needham on November 25, 2025, initiated with a Buy rating and assigned the stock a target price of $5.
On July 23, 2025, Noble Capital Markets started tracking the stock assigning a Outperform rating and target price of $8.
On July 16, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $6.B. Riley Securities initiated its Buy rating on July 16, 2025, with a $6 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 02 ’26 when Carter Robert Ross sold 247 shares for $3.56 per share. The transaction valued at 879 led to the insider holds 235,122 shares of the business.
Hively Brad sold 13,333 shares of TOI for $50,291 on Dec 15 ’25. The Director now owns 683,721 shares after completing the transaction at $3.77 per share. On Dec 15 ’25, another insider, BRADFORD DANIEL HIVELY, who serves as the Director of the company, bought 13,333 shares for $3.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOI now has a Market Capitalization of 347286144 and an Enterprise Value of 423252128. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.75. Its current Enterprise Value per Revenue stands at 0.918 whereas that against EBITDA is -12.417.
Stock Price History:
The Beta on a monthly basis for TOI is 0.17, which has changed by 8.625 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, TOI has reached a high of $4.88, while it has fallen to a 52-week low of $0.27. The 50-Day Moving Average of the stock is -1.27%, while the 200-Day Moving Average is calculated to be 9.36%.
Shares Statistics:
TOI traded an average of 2.30M shares per day over the past three months and 2043520 shares per day over the past ten days. A total of 97.57M shares are outstanding, with a floating share count of 69.62M. Insiders hold about 29.23% of the company’s shares, while institutions hold 31.15% stake in the company. Shares short for TOI as of 1767139200 were 5803785 with a Short Ratio of 2.52, compared to 1764288000 on 6567704. Therefore, it implies a Short% of Shares Outstanding of 5803785 and a Short% of Float of 7.12.
